COVID-19 pneumonia in an HIV-positive woman on antiretroviral therapy and undetectable viral load in Porto Alegre, Brazil

AUTOR(ES)

Cipolat, Murillo Machado; Sprinz, Eduardo

FONTE

Braz J Infect Dis

DATA DE PUBLICAÇÃO

2020-10

RESUMO

Abstract COVID-19 pandemic has been a problem worldwide. It is important to identify people at risk of progressing to severe complications and to investigate if some existing antivirals could have any action against SARS-CoV-2. In this context, HIV-infected individuals and antiretroviral drugs might be included, respectively. Herein we present the case of a 63-year-old HIV-infected woman with undetectable viral load, on dolutegravir, tenofovir and lamivudine, who was hospitalized due to COVID-19 pneumonia. In spite of having some clinical markers of severity on admission, the patient improved and was discharged after a week. To our knowledge, this is the first report of severe SARS-CoV-2 infection in an HIV-infected individual in Brazil.

Documentos Relacionados

• Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil
• Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
• Different nutritional-state indicators of HIV-positive individuals undergoing antiretroviral therapy
• Nutritional status and lipid profile of HIV-positive children and adolescents using antiretroviral therapy
• Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy